Dynamic Interleukin-1 Receptor Type 1 Signaling Mediates Microglia-Vasculature Interactions Following Repeated Systemic LPS

References

• Amini E, Golpich M, Farjam AS, et al. Brain lipopolysaccharide preconditioning-induced gene reprogramming mediates a tolerance state in electroconvulsive shock model of epilepsy. Front Pharmacol. 2018;9. doi:10.3389/fphar.2018.00416
   PubMed Web of Science ®Google Scholar
• Chen Z, Jalabi W, Shpargel KB, et al. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci. 2012;32(34):11706–11715. doi:10.1523/JNEUROSCI.0730-12.2012
   PubMed Web of Science ®Google Scholar
• Rosenzweig Holly L, Lessov Nikola S, Henshall David C, Manabu M, Simon Roger P, Stenzel-Poore Mary P. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke. 2004;35(11):2576–2581. doi:10.1161/01.STR.0000143450.04438.ae
   PubMed Web of Science ®Google Scholar
• Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS, Stenzel-Poore MP. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J Neuroinflammation. 2011;8(1):140. doi:10.1186/1742-2094-8-140
   PubMed Web of Science ®Google Scholar
• Freria CM, Brennan FH, Sweet DR, et al. Serial systemic injections of endotoxin (LPS) elicit neuroprotective spinal cord microglia through IL-1-dependent cross talk with endothelial cells. J Neurosci. 2020;40(47):9103–9120. doi:10.1523/JNEUROSCI.0131-20.2020
   PubMed Web of Science ®Google Scholar
• Neher JJ, Cunningham C. Priming microglia for innate immune memory in the brain. Trends Immunol. 2019;40(4):358–374. doi:10.1016/j.it.2019.02.001
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Okazaki R, Morioka K, Nakamura K, Tanaka S, Ogata T. Lipopolysaccharide preconditioning facilitates M2 activation of resident microglia after spinal cord injury. J Neurosci Res. 2014;92(12):1647–1658. doi:10.1002/jnr.23448
   PubMed Web of Science ®Google Scholar
• Banks WA, Robinson SM. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav Immun. 2010;24(1):102–109. doi:10.1016/j.bbi.2009.09.001
   PubMed Web of Science ®Google Scholar
• Chakravarty S. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci. 2005;25(7):1788–1796. doi:10.1523/JNEUROSCI.4268-04.2005
   PubMed Web of Science ®Google Scholar
• Lacroix S, Feinstein D, Rivest S. The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol. 1998;8(4):625–640. doi:10.1111/j.1750-3639.1998.tb00189.x
   PubMed Web of Science ®Google Scholar
• Zhu L, Liu X, Nemeth DP, et al. Interleukin-1 causes CNS inflammatory cytokine expression via endothelia-microglia bi-cellular signaling. Brain Behav Immun. 2019;81:292–304. doi:10.1016/j.bbi.2019.06.026
   PubMed Web of Science ®Google Scholar
• Liu X, Yamashita T, Chen Q, et al. Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor-mediated effects in specific cell types. J Neurosci. 2015;35(7):2860–2870. doi:10.1523/JNEUROSCI.3199-14.2015
   PubMed Web of Science ®Google Scholar
• Liu X, Nemeth DP, McKim DB, et al. Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities. Immunity. 2019;50(2):317–333.e6. doi:10.1016/j.immuni.2018.12.012
   PubMed Web of Science ®Google Scholar
• Krasnow SM, Knoll JG, Verghese SC, Levasseur PR, Marks DL. Amplification and propagation of interleukin-1β signaling by murine brain endothelial and glial cells. J Neuroinflammation. 2017;14(1). doi:10.1186/s12974-017-0908-4
   Web of Science ®Google Scholar
• Skelly DT, Griffin ÉW, Murray CL, et al. Acute transient cognitive dysfunction and acute brain injury induced by systemic inflammation occur by dissociable IL-1-dependent mechanisms. Mol Psychiatry. 2019;24(10):1533–1548. doi:10.1038/s41380-018-0075-8
   PubMed Web of Science ®Google Scholar
• Turner M, Chantry D, Buchan G, Barrett K, Feldmann M. Regulation of expression of human IL-1 alpha and IL-1 beta genes. J Immunol. 1989;143(11):3556–3561.
   PubMed Web of Science ®Google Scholar
• Matsuwaki T, Shionoya K, Ihnatko R, et al. Involvement of interleukin-1 type 1 receptors in lipopolysaccharide-induced sickness responses. Brain Behav Immun. 2017;66:165–176. doi:10.1016/j.bbi.2017.06.013
   PubMed Web of Science ®Google Scholar
• Paeschke N, Von Haefen C, Endesfelder S, Sifringer M, Spies CD. Dexmedetomidine prevents lipopolysaccharide-induced microRNA expression in the adult rat brain. Int J Mol Sci. 2017;18(9):1830. doi:10.3390/ijms18091830
   PubMed Web of Science ®Google Scholar
• Quan N, Whiteside M, Herkenham M. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience. 1998;83(1):281–293. doi:10.1016/S0306-4522(97)00350-3
   PubMed Web of Science ®Google Scholar
• Pinteaux E, Parker LC, Rothwell NJ, Luheshi GN. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J Neurochem. 2002;83(4):754–763. doi:10.1046/j.1471-4159.2002.01184.x
   PubMed Web of Science ®Google Scholar
• McKim DB, Patterson JM, Wohleb ES, et al. Sympathetic release of splenic monocytes promotes recurring anxiety following repeated social defeat. Biol Psychiatry. 2016;79(10):803–813. doi:10.1016/j.biopsych.2015.07.010
   PubMed Web of Science ®Google Scholar
• McKim DB, Niraula A, Tarr AJ, Wohleb ES, Sheridan JF, Godbout JP. Neuroinflammatory dynamics underlie memory impairments after repeated social defeat. J Neurosci. 2016;36(9):2590–2604. doi:10.1523/JNEUROSCI.2394-15.2016
   PubMed Web of Science ®Google Scholar
• Norden DM, Trojanowski PJ, Villanueva E, Navarro E, Godbout JP. Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge. Glia. 2016;64(2):300–316. doi:10.1002/glia.22930
   PubMed Web of Science ®Google Scholar
• Haruwaka K, Ikegami A, Tachibana Y, et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun. 2019;10(1):5816. doi:10.1038/s41467-019-13812-z
   PubMed Web of Science ®Google Scholar
• Friedman BA, Srinivasan K, Ayalon G, et al. Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of alzheimer’s disease not evident in mouse models. Cell Rep. 2018;22(3):832–847. doi:10.1016/j.celrep.2017.12.066
   PubMed Web of Science ®Google Scholar
• Srinivasan K, Friedman BA, Etxeberria A, et al. Alzheimer’s patient microglia exhibit enhanced aging and unique transcriptional activation. Cell Rep. 2020;31(13):107843. doi:10.1016/j.celrep.2020.107843
   PubMed Web of Science ®Google Scholar
• Lin H-Y, Wu C-L, Huang -C-C. The akt-endothelial nitric oxide synthase pathway in lipopolysaccharide preconditioning-induced hypoxic-ischemic tolerance in the neonatal rat brain. Stroke. 2010;41(7):1543–1551. doi:10.1161/STROKEAHA.109.574004
   PubMed Web of Science ®Google Scholar
• Wada Y, Otu H, Wu S, et al. Preconditioning of primary human endothelial cells with inflammatory mediators alters the “set point” of the cell. FASEB J. 2005;19(13):1914–1916. doi:10.1096/fj.05-4037fje
   PubMed Web of Science ®Google Scholar
• Fenn AM, Henry CJ, Huang Y, Dugan A, Godbout JP. Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice. Brain Behav Immun. 2012;26(5):766–777. doi:10.1016/j.bbi.2011.10.003
   PubMed Web of Science ®Google Scholar
• Qin Y, Sun X, Shao X, et al. Lipopolysaccharide preconditioning induces an anti-inflammatory phenotype in BV2 microglia. Cell Mol Neurobiol. 2016;36(8):1269–1277. doi:10.1007/s10571-015-0324-1
   PubMed Web of Science ®Google Scholar
• Schaafsma W, Zhang X, van Zomeren KC, et al. Long-lasting pro-inflammatory suppression of microglia by LPS-preconditioning is mediated by RelB-dependent epigenetic silencing. Brain Behav Immun. 2015;48:205–221. doi:10.1016/j.bbi.2015.03.013
   PubMed Web of Science ®Google Scholar
• Smithason S, Moore SK, Provencio JJ. Low-dose lipopolysaccharide injection prior to subarachnoid hemorrhage modulates delayed deterioration associated with vasospasm in subarachnoid hemorrhage. Acta Neurochir Suppl. 2013;115:253–258. doi:10.1007/978-3-7091-1192-5_45
   PubMedGoogle Scholar
• Banks WA, Gray AM, Erickson MA, et al. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation. 2015;12(1). doi:10.1186/s12974-015-0434-1
   PubMed Web of Science ®Google Scholar
• Jin L, Nation RL, Li J, Nicolazzo JA. Species-dependent blood-brain barrier disruption of lipopolysaccharide: amelioration by colistin in vitro and in vivo. Antimicrob Agents Chemother. 2013;57(9):4336–4342. doi:10.1128/AAC.00765-13
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29(43):13435–13444. doi:10.1523/JNEUROSCI.3257-09.2009
   PubMed Web of Science ®Google Scholar
• Sato A, Ohtaki H, Tsumuraya T, et al. Interleukin-1 participates in the classical and alternative activation of microglia/macrophages after spinal cord injury. J Neuroinflammation. 2012;9(1):65. doi:10.1186/1742-2094-9-65
   PubMed Web of Science ®Google Scholar
• DiSabato DJ, Nemeth DP, Liu X, et al. Interleukin-1 receptor on hippocampal neurons drives social withdrawal and cognitive deficits after chronic social stress. Mol Psychiatry. 2020:1–13. doi:10.1038/s41380-020-0788-3.
   Web of Science ®Google Scholar
• Greten FR, Arkan MC, Bollrath J, et al. NF-κB Is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ. Cell. 2007;130(5):918–931. doi:10.1016/j.cell.2007.07.009
   PubMed Web of Science ®Google Scholar
• Batista SJ, Still KM, Johanson D, et al. Gasdermin-D-dependent IL-1α release from microglia promotes protective immunity during chronic Toxoplasma gondii infection. Nat Commun. 2020;11(1):3687. doi:10.1038/s41467-020-17491-z
   PubMed Web of Science ®Google Scholar